Therapeuticsmd Inc (TXMD)

Aug 12, 2026

TherapeuticsMD Q2 2026 License Revenue Drops 8.7% Year Over Year - clinicaltrialvanguard.com

Aug 12, 2026

Aug 11, 2026

TherapeuticsMD Q2 Net Income From Cont Ops US - Moomoo

Aug 11, 2026

Aug 11, 2026

TherapeuticsMD: Q2 Earnings Snapshot - AOL.com

Aug 11, 2026

Aug 11, 2026

TherapeuticsMD Q2 EPS drops 80% to $0.01 on sales slide - scanx.trade

Aug 11, 2026

Aug 11, 2026

Is TherapeuticsMD Inc (TXMD) Positioned for Growth After Q2 Earn - GuruFocus

Aug 11, 2026

Aug 11, 2026

TherapeuticsMD Q2 Results and Strategic Alternatives Review - TipRanks

Aug 11, 2026

Aug 11, 2026

TherapeuticsMD, Inc. Q2 2026: Revenue $869K, EPS $0.01— 10-Q Summary - TradingView

Aug 11, 2026

Aug 11, 2026

TherapeuticsMD Q2 license revenue falls; continues to evaluate strategic alternatives - TradingView

Aug 11, 2026

Aug 11, 2026

TherapeuticsMD Q2 2026 License Revenue Falls to $869000 - Quiver Quantitative

Aug 11, 2026

Aug 11, 2026

TherapeuticsMD Q2 2026 Earnings: License Revenue and Net Income Decline - tradingkey.com

Aug 11, 2026

Aug 11, 2026

TXMD: Q2 2026 saw lower net income and license revenue, with strategic alternatives under evaluation - TradingView

Aug 11, 2026

Aug 11, 2026

TherapeuticsMD (TXMD) posts Q2 2026 update and weighs strategic alternatives - Stock Titan

Aug 11, 2026

Aug 11, 2026

TherapeuticsMD to Recognize About $365K IMVEXXY Milestone in Q3 - Stock Titan

Aug 11, 2026

Aug 08, 2026

TherapeuticsMD, Inc. (29TA.SG) stock price, news, quote and history - Yahoo Finance Australia

Aug 08, 2026

Aug 05, 2026

TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch

Aug 05, 2026

Aug 05, 2026

Baselake group (TXMD) discloses 6.8% beneficial stake in TherapeuticsMD common stock - Stock Titan

Aug 05, 2026

Aug 03, 2026

CNSY Stock Price and Chart — NASDAQ:CNSY - TradingView

Aug 03, 2026

Aug 02, 2026

TherapeuticsMD, Inc. (29TA.SG) Stock Price, News, Quote & History - Yahoo! Finance Canada

Aug 02, 2026

Aug 01, 2026

TherapeuticsMD (TXMD) Holds Steady at $2.03 as Trading Range NarrowsVolume Rate Change - dars.gov.et

Aug 01, 2026

Jul 31, 2026

TXMD|TherapeuticsMD Inc|Price:2.090|Chg%:+0.060 - tradingkey.com

Jul 31, 2026

Jul 30, 2026

TherapeuticsMD Inc. (TXMD) Slips Further: Key Support Levels Under PressurePCR Spike - dars.gov.et

Jul 30, 2026

Jul 30, 2026

TherapeuticsMD Inc. stock outperforms competitors despite losses on the day - MarketWatch

Jul 30, 2026

Jul 28, 2026

TherapeuticsMD, Inc. Revenue Breakdown – SWB:29TA - TradingView

Jul 28, 2026

Jul 27, 2026

TherapeuticsMD Inc (TXMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jul 27, 2026

Jul 27, 2026

TherapeuticsMD Inc (TXMD) Cash Flow - TradingKey

Jul 27, 2026

Jul 27, 2026

TherapeuticsMD Inc (TXMD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 27, 2026

Jul 26, 2026

TherapeuticsMD Inc (TXMD) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jul 26, 2026

Jul 26, 2026

TherapeuticsMD, Inc. Revenue Breakdown – MUN:29TA - TradingView

Jul 26, 2026

Jul 26, 2026

TherapeuticsMD Inc (TXMD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jul 26, 2026

Jul 26, 2026

TherapeuticsMD Inc (TXMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jul 26, 2026

Jul 26, 2026

TXMD|TherapeuticsMD Inc|Price:2.060| - TradingKey

Jul 26, 2026

Jul 26, 2026

TXMD|TherapeuticsMD Inc|Price:2.070| - tradingkey.com

Jul 26, 2026

Jul 25, 2026

TherapeuticsMD (TXMD) Holds Steady at $2.06 as Consolidation ContinuesPut Support - dars.gov.et

Jul 25, 2026

Jul 24, 2026

TherapeuticsMD Inc (TXMD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jul 24, 2026

Jul 21, 2026

TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Jul 21, 2026

Jul 15, 2026

TherapeuticsMD Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Jul 15, 2026

Jul 13, 2026

TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch

Jul 13, 2026

Jul 11, 2026

TherapeuticsMD Company Profile & Introduction - Moomoo

Jul 11, 2026

Jul 10, 2026

TXMD Q3 2023 Earnings: Significant EPS Miss Amid Ongoing ChallengesEarnings Call Highlights - DonanımHaber

Jul 10, 2026

Jul 07, 2026

TherapeuticsMD (TXMD) News Flow - Moomoo

Jul 07, 2026

Jul 07, 2026

TherapeuticsMD (TXMD) Edges Higher, Consolidating Near $2.00New Highs New Lows - dars.gov.et

Jul 07, 2026

Jul 02, 2026

TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Jul 02, 2026

Jul 01, 2026

TXMD Q3 2023 Earnings: Significant EPS Miss Highlights Ongoing Revenue ChallengesReturn On Capital - dars.gov.et

Jul 01, 2026

Jun 28, 2026

TXMD Q3 2023 Earnings: Significant EPS Miss as Company Faces Operational ChallengesEarnings Risk Report - dars.gov.et

Jun 28, 2026

Jun 27, 2026

TherapeuticsMD (TXMD) Rallies 3.94% as Stock Approaches Key Resistance at $2.22Stop Run - dars.gov.et

Jun 27, 2026

Jun 26, 2026

TherapeuticsMD Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch

Jun 26, 2026

Jun 26, 2026

Price to earnings forward of TherapeuticsMD, Inc. – NASDAQ:TXMD - TradingView

Jun 26, 2026

Jun 26, 2026

Enterprise value to revenue forward of TherapeuticsMD, Inc. – NASDAQ:TXMD - TradingView

Jun 26, 2026

Jun 24, 2026

TherapeuticsMD Inc (TXMD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 24, 2026

Jun 22, 2026

TherapeuticsMD Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch

Jun 22, 2026

Jun 22, 2026

TherapeuticsMD Inc (TXMD) Institutional Confidence - TradingKey

Jun 22, 2026

Jun 18, 2026

TherapeuticsMD Inc (TXMD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 18, 2026